The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Subscribe To Our Newsletter & Stay Updated
